Pfizer oral Covid-19 pill gets US authorization for at-home use

Data from Pfizer's clinical trial showed its two-drug antiviral regimen was 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness.

Pfizer said it plans to file a new drug application with the FDA in 2022 for potential full regulatory approval. (Reuters)

Pfizer Inc said on Wednesday the U.S. Food and Drug Administration authorized its antiviral COVID-19 pill, making it the first at-home treatment for the coronavirus that is expected to become an important tool in the fight against the fast spreading Omicron variant.

Data from Pfizer’s clinical trial showed its two-drug antiviral regimen was 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness.

Explained | What is the process for Pfizer's Paxlovid to come to India?

Recent lab data suggests the drug retains its effectiveness against Omicron.The agency authorized the oral drug for the treatment of high-risk adult patients and pediatric patients at least 12 years of age with COVID-19 outside of the hospital.

Story continues below this ad

The company said it was ready to start immediate delivery in the U.S. and raised its production projections to 120 million courses of treatment from 80 million in 2022.

The U.S. government’s contract for 10 million courses of the Pfizer drug is priced at $530 per course.The Pfizer pills, taken with the older antiviral drug ritonavir, will be sold under the brand name Paxlovid. The pills are meant to be taken every 12 hours for five days beginning shortly after the onset of symptoms.

Pfizer said it plans to file a new drug application with the FDA in 2022 for potential full regulatory approval.

Stay updated with the latest - Click here to follow us on Instagram

Tags:
pfizer

exporters not lose market share, labour-intensive exporters, india us trade deal, Trump Tariffs, trump tariff impositions, India-US ties, trade war, us trade war, donald trump, reciprocal tariffs, Trump India trade deal, India US tariff cuts, Trump India tariffs announcement, India US trade agreement, Modi Trump trade talks, India US economic relations, India lowers tariffs for US, US India trade negotiations, Trump Modi tariff deal, India US import export policy, Trump on India tariffs, US India business ties, trade war India US, India trade policy changes, India US tariff reduction, Indian express news, current affairs

On Govt table: How to help exporters not lose market share due to 50% US tariff

Business2 hr ago

The Indian government is implementing strategies to protect its market share from the impact of high US tariffs. This includes providing support to exporters through subsidies, loans, and credit guarantees, as well as helping them access domestic buyers. However, India's export growth to US is lower compared to its competitors, and the situation may worsen with additional tariffs on Russian oil.

View all shorts

Live Blog